Anna Powitz-Starzinski

Max Von Laue Str. 13
Laue, SN 60438, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Lysophosphatidic acid triggers cathepsin B-mediated invasiveness of human endometriotic cells.

Lysophosphatidic acid triggers cathepsin B-mediated invasiveness of human endometriotic cells.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: March 02, 2018

Endogenous AJAP1 associates with the cytoskeleton and attenuates angiogenesis in endothelial cells.

Endogenous AJAP1 associates with the cytoskeleton and attenuates angiogenesis in endothelial cells.

Journal: Biology open

Published: May 10, 2017

Alternative exon usage creates novel transcript variants of tumor suppressor SHREW-1 gene with differential tissue expression profile.

Alternative exon usage creates novel transcript variants of tumor suppressor SHREW-1 gene with differential tissue expression profile.

Journal: Biology open

Published: November 22, 2016

Molecular and Cellular Pathogenesis of Endometriosis.

Molecular and Cellular Pathogenesis of Endometriosis.

Journal: Current women's health reviews

Published: April 29, 2016

Syndecan-4 expression is upregulated in endometriosis and contributes to an invasive phenotype.

Syndecan-4 expression is upregulated in endometriosis and contributes to an invasive phenotype.

Journal: Fertility and sterility

Published: January 30, 2016

microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4.

microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4.

Journal: Reproductive biomedicine online

Published: July 30, 2015

Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.

Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 23, 2015

PAI-1 secretion of endometrial and endometriotic cells is Smad2/3- and ERK1/2-dependent and influences cell adhesion.

PAI-1 secretion of endometrial and endometriotic cells is Smad2/3- and ERK1/2-dependent and influences cell adhesion.

Journal: American journal of translational research

Published: March 09, 2015

Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells.

Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells.

Journal: Molecular and cellular endocrinology

Published: March 02, 2015

Novel three-dimensional in vitro models of ovarian endometriosis.

Novel three-dimensional in vitro models of ovarian endometriosis.

Journal: Journal of ovarian research

Published: August 29, 2013

Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms.

Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms.

Journal: Biology of reproduction

Published: December 18, 2012

Ligand activation of peroxisome proliferator-activated receptor delta suppresses cathepsin B expression in human endothelial cells in a posttranslational manner.

Ligand activation of peroxisome proliferator-activated receptor delta suppresses cathepsin B expression in human endothelial cells in a posttranslational manner.

Journal: Experimental dermatology

Published: October 20, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026